Percutaneous ablation of pancreatic cancer

Pancreatic ductal adenocarcinoma is a highly aggressive tumor with an overall 5-year survival rate of less than 5%. Prognosis and treatment depend on whether the tumor is resectable or not, which mostly depends on how quickly the diagnosis is made. Chemotherapy and radiotherapy can be both used in c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Gastroenterol
Autors principals: D’Onofrio, Mirko, Ciaravino, Valentina, De Robertis, Riccardo, Barbi, Emilio, Salvia, Roberto, Girelli, Roberto, Paiella, Salvatore, Gasparini, Camilla, Cardobi, Nicolò, Bassi, Claudio
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2016
Matèries:
Editorial
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5124972/
https://ncbi.nlm.nih.gov/pubmed/27956791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i44.9661
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars